Press release
11/19/2024 Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO SystemWould you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.
You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.
The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.
Press release
11/19/2024 Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO SystemPress release
11/18/2024 Fresenius Medical Care’s AI-Powered Application of the Anemia Control Model Selected for CMS AI Demo Days in the United StatesShort News
11/14/2024 Fresenius Medical Care launches the "Living Well" campaign on World Diabetes Day to raise awareness for patients living with diabetes, which is one of the leading causes of chronic kidney diseasePress release
11/05/2024 Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024Short News
11/01/2024 Fresenius Medical Care and CEO Helen Giza Ranked Among Top 100 Women-Led Businesses in MassachusettsPress release
10/24/2024 Fresenius Medical Care Recent Study Validates Innovative Anemia Therapy Software Improves Clinical Outcomes for Hemodialysis PatientsMedia Statement
10/21/2024 Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024Press release
10/15/2024 Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0Related content